TOP2A and non-small cell lung carcinoma: Our IHC experiment which was conducted on 107 cases of local hospitalized NSCLC patients surgery samples also confirmed the results, significant TOP2A gain of expression ratio (36.4%) in NSCLC was observed by IHC staining in verse the low ratio (less than 1%) in normal tissues.